Johnson & JohnsonShort
$JNJ Looks a certain short from here. $120 NEXT STOP
*****INVESTORS IN JNJ CAN'T WAIT FOR MAY TO BE OVER, ALREADY DOWN 7% AND 5% IN ONE DAY , NEXT SUPPORT IS ANOTHER 6% AWAY AND IT LOOKS VERY MUCH LIKE THAT IS WHERE THE PRICE IS GOING. OPIOID LITIGATIONS CONTINUE TO BE A DRAG ON SENTIMENT AND THAT ISSUE WILL INTENSIFY AS THE CRISIS INTENSIFIES.
AVERAGE ANALYSTS RETAIL PRICE $148
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 24
JNJ CAN'T WAIT FOR MAY TO BE OVER, ALREADY DOWN 7% AND 5% IN ONE DAY , NEXT SUPPORT IS ANOTHER 6% AWAY AND IT LOOKS VERY MUCH LIKE THAT IS WHERE THE PRICE IS GOING. OPIOID LITIGATIONS CONTINUE TO BE A DRAG ON SENTIMENT AND THAT ISSUE WILL INTENSIFY AS THE CRISIS INTENSIFIES. AVERAGE ANALYSTS RETAIL PRICE $148
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/E RATIO 24
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.